Home
Conditions
Neoplasms, Neuroepithelial

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,959 public trials 647 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Completed

Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome

NCT00806182

Conditions: Ataxia, Autoimmune Diseases, Central Nervous System Diseases, +27 more
Locations: National Pediatric Myoclonus Center, Formerly at Dept. of Neurology, Southern Illinois University School of Medicine Springfield, Illinois, United States

View Trial Details

Completed

Evaluating Dactinomycin and Vincristine in Young Patients With Cancer

NCT00674193

Conditions: Childhood Acute Lymphoblastic Leukemia, Childhood Rhabdomyosarcoma, Childhood Soft Tissue Sarcoma, +44 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Miller Children's Hospital Long Beach, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Childrens Hospital of Orange County Orange, California, United States

View all 38 locations

View Trial Details

Completed

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

NCT01288573

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumors, +16 more
Locations: Investigational Site Number 51 Ghent, Belgium

Investigational Site Number 81 Brno, Czechia

Investigational Site Number 82 Praha 5 - Motol, Czechia

Investigational Site Number 61 København Ø, Denmark

View all 27 locations

View Trial Details

Completed

A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)

NCT00345163

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
Locations: Not specified

View Trial Details

Completed

SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745)

NCT00783393

Conditions: Astrocytoma, Glioma, Neoplasms, +6 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)

NCT00335075

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Not specified

View Trial Details

Completed

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

NCT00509691

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Completed

A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas

NCT00589706

Conditions: Glioma, Gliomas, Neoplasms, +6 more
Locations: Hahneman Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma

NCT01241162

Conditions: Disease Attributes, Ewings Sarcoma, Myosarcoma, +24 more
Locations: University of Louisville, Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States

View Trial Details

Completed

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

NCT00248547

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +100 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Neoplasms, Neuroepithelial

Neoplasms, Neuroepithelial trial results

Related conditions